Literature DB >> 15003276

The E318G substitution in PSEN1 gene is not connected with Alzheimer's disease in a large Polish cohort.

Cezary Zekanowski1, Beata Pepłońska, Maria Styczyńska, Dorota Religa, Anna Pfeffer, Krzysztof Czyzewski, Tomasz Gabryelewicz, Aleksandra Szybińska, Beata Kijanowska-Haładyna, Sławomira Kotapka-Minc, Elzbieta Łuczywek, Anna Barczak, Bogusław Wasiak, Małgorzata Chodakowska-Zebrowska, Izabela Przekop, Jacek Kuźnicki, Maria Barcikowska.   

Abstract

Mutations in the presenilin 1 (PSEN1) gene are known to cause nearly 50% of early-onset, familial Alzheimer's disease (AD) cases. To determine whether E318G mutation is related causally to AD in the Polish population E318G mutation frequency was assessed using PCR-RFLP method in a total of 659 subjects: 256 AD patients, 210 healthy, age-matched control subjects, 100 Parkinson's disease patients and 93 centenarians. When the mutation frequencies were compared to healthy controls, no significant differences between the groups were found. It could be concluded that E318G mutation is not related causally to AD in the Polish population, either as a risk factor or a disease causing mutation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15003276     DOI: 10.1016/j.neulet.2003.12.052

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Familial Alzheimer's disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein.

Authors:  Oksana Berezovska; Alberto Lleo; Lauren D Herl; Matthew P Frosch; Edward A Stern; Brian J Bacskai; Bradley T Hyman
Journal:  J Neurosci       Date:  2005-03-16       Impact factor: 6.167

2.  Atypical Huntington's disease with the clinical presentation of behavioural variant of frontotemporal dementia.

Authors:  Stanislav Sutovsky; Tomas Smolek; Irina Alafuzoff; Andrej Blaho; Vojtech Parrak; Peter Turcani; Michal Palkovic; Robert Petrovic; Michal Novak; Norbert Zilka
Journal:  J Neural Transm (Vienna)       Date:  2016-06-10       Impact factor: 3.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.